Global Cancer Biomarkers Report Thumbnail

Global Cancer Biomarkers Market by Type (Protein Biomarkers, Genetic Biomarkers, Others), By Application (Hospital, Diagnostic Center, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: CM-36555
  • Author: Up Market Research
  • Rating: 4.8
  • Total Reviews: 71
  • No. Of Pages: 230
  • Format:
  • Pub. Date: 2021-04-04
  • Share:

Up Market Research published a new report titled “Cancer Biomarkers Market research report which is segmented by Types (Protein Biomarkers, Genetic Biomarkers, Others), By Applications (Hospital, Diagnostic Center, Others), By Players/Companies Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Illumina,Inc., Agilent Technologies, Qiagen NV, Merck & Co., Hologic,Inc., Novartis AG, BioMerieux SA, Genomic Health, Affymetrix, Roche Diagnostics Ltd.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

Report AttributesReport Details
Report TitleCancer Biomarkers Market Research Report
By TypeProtein Biomarkers, Genetic Biomarkers, Others
By ApplicationHospital, Diagnostic Center, Others
By CompaniesAbbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Illumina,Inc., Agilent Technologies, Qiagen NV, Merck & Co., Hologic,Inc., Novartis AG, BioMerieux SA, Genomic Health, Affymetrix, Roche Diagnostics Ltd.
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages230
Number of Tables & Figures161
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Cancer Biomarkers Industry Outlook

Global Cancer Biomarkers Market Report Segments:

The market is segmented by Type Protein Biomarkers, Genetic Biomarkers, Others and By Application Hospital, Diagnostic Center, Others.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. Thermo Fisher Scientific
  3. F. Hoffmann-La Roche Ltd
  4. Illumina,Inc.
  5. Agilent Technologies
  6. Qiagen NV
  7. Merck & Co.
  8. Hologic,Inc.
  9. Novartis AG
  10. BioMerieux SA
  11. Genomic Health
  12. Affymetrix
  13. Roche Diagnostics Ltd.

Cancer Biomarkers Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Cancer Biomarkers Market

Overview of the regional outlook of the Cancer Biomarkers Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Cancer Biomarkers Market Overview

Highlights of The Cancer Biomarkers Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Cancer Biomarkers Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Protein Biomarkers

                2. Genetic Biomarkers

                3. Others

       7. By Application:

                1. Hospital

                2. Diagnostic Center

                3. Others

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cancer Biomarkers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Cancer Biomarkers Market Statistics

Reasons to Purchase the Cancer Biomarkers Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Biomarkers Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Cancer Biomarkers Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Cancer Biomarkers Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Cancer Biomarkers Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Cancer Biomarkers Market Size & Forecast, 2018-2028 
      4.5.1 Cancer Biomarkers Market Size and Y-o-Y Growth 
      4.5.2 Cancer Biomarkers Market Absolute $ Opportunity 

Chapter 5 Global Cancer Biomarkers Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Cancer Biomarkers Market Size Forecast by Type
      5.2.1 Protein Biomarkers
      5.2.2 Genetic Biomarkers
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Cancer Biomarkers Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Cancer Biomarkers Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Diagnostic Center
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Cancer Biomarkers Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cancer Biomarkers Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Cancer Biomarkers Analysis and Forecast
   9.1 Introduction
   9.2 North America Cancer Biomarkers Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Cancer Biomarkers Market Size Forecast by Type
      9.6.1 Protein Biomarkers
      9.6.2 Genetic Biomarkers
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Cancer Biomarkers Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Diagnostic Center
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Cancer Biomarkers Analysis and Forecast
   10.1 Introduction
   10.2 Europe Cancer Biomarkers Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Cancer Biomarkers Market Size Forecast by Type
      10.6.1 Protein Biomarkers
      10.6.2 Genetic Biomarkers
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Cancer Biomarkers Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Diagnostic Center
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Cancer Biomarkers Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Cancer Biomarkers Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Cancer Biomarkers Market Size Forecast by Type
      11.6.1 Protein Biomarkers
      11.6.2 Genetic Biomarkers
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Cancer Biomarkers Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Diagnostic Center
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Cancer Biomarkers Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Cancer Biomarkers Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Cancer Biomarkers Market Size Forecast by Type
      12.6.1 Protein Biomarkers
      12.6.2 Genetic Biomarkers
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Cancer Biomarkers Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Diagnostic Center
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Cancer Biomarkers Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Cancer Biomarkers Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Cancer Biomarkers Market Size Forecast by Type
      13.6.1 Protein Biomarkers
      13.6.2 Genetic Biomarkers
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Cancer Biomarkers Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Diagnostic Center
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Cancer Biomarkers Market: Competitive Dashboard
   14.2 Global Cancer Biomarkers Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Abbott Laboratories
      14.3.2 Thermo Fisher Scientific
      14.3.3 F. Hoffmann-La Roche Ltd
      14.3.4 Illumina,Inc.
      14.3.5 Agilent Technologies
      14.3.6 Qiagen NV
      14.3.7 Merck & Co.
      14.3.8 Hologic,Inc.
      14.3.9 Novartis AG
      14.3.10 BioMerieux SA
      14.3.11 Genomic Health
      14.3.12 Affymetrix
      14.3.13 Roche Diagnostics Ltd.
Segments Covered in the Report
The global Cancer Biomarkers market has been segmented based on

By Types
  • Protein Biomarkers
  • Genetic Biomarkers
  • Others
By Applications
  • Hospital
  • Diagnostic Center
  • Others
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd
  • Illumina,Inc.
  • Agilent Technologies
  • Qiagen NV
  • Merck & Co.
  • Hologic,Inc.
  • Novartis AG
  • BioMerieux SA
  • Genomic Health
  • Affymetrix
  • Roche Diagnostics Ltd.

Buy Report